Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy - Concepedia

Concepedia

Publication | Closed Access

Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy

91

Citations

23

References

2008

Year

Elke Martin, Annemette Thougaard, Morten Grauslund, Peter Buhl Jensen, Fredrik Björkling, Brian B. Hasinoff, Jette Tjørnelund, Maxwell Sehested, Lars H. Jensen

Medicinal ChemistryHeart FailurePharmacologyCardiovascular PharmacologyDoxorubicin-induced CardiomyopathyPharmacotherapyCardiovascular ToxicityMedicineDrug DiscoveryDrug Resistance

References

	Year	Citations

Page 1

Page 1